Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · IEX Real-Time Price · USD

14.02

-1.59 (-10.19%)

At close: Jul 2, 2024, 4:00 PM

14.72

+0.70 (4.99%)

After-hours: Jul 2, 2024, 7:19 PM EDT

Lexeo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-66.39	-59.28	-50.62
Depreciation & Amortization	1.84	1.15	0.01
Share-Based Compensation	3.04	1.78	0.39
Other Operating Activities	2.01	1.79	6.04
Operating Cash Flow	-59.5	-54.56	-44.18
Capital Expenditures	-0.12	-0.67	-0.19
Other Investing Activities	-0.05	-0.23	-
Investing Cash Flow	-0.17	-0.9	-0.19
Share Issuance / Repurchase	100.3	0.33	0.17
Debt Issued / Paid	3.49	-0.16	0
Other Financing Activities	-	0.02	150.69
Financing Cash Flow	103.79	0.19	150.86
Net Cash Flow	44.13	-55.27	106.49
Free Cash Flow	-59.61	-55.23	-44.37
Free Cash Flow Margin	-	-8445.26%	-2677.73%
Free Cash Flow Per Share	-11.13	-33.88	-28.58

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).